Drugs News and Research

RSS
Scientists discover killer protein that protects against development of cancer

Scientists discover killer protein that protects against development of cancer

Phase III trial results: Erlotinib has comparable efficacy to chemotherapy with better tolerability against lung cancer

Phase III trial results: Erlotinib has comparable efficacy to chemotherapy with better tolerability against lung cancer

Encouraging preliminary results from Synta's ganetespib Phase 2 trial against non-small cell lung cancer

Encouraging preliminary results from Synta's ganetespib Phase 2 trial against non-small cell lung cancer

Avastin debate spills over until June FDA hearing

Avastin debate spills over until June FDA hearing

U.S.-Chile collaborate to study new long-acting local anesthetic derived from algae

U.S.-Chile collaborate to study new long-acting local anesthetic derived from algae

Discovery highlights unexpected role for killer protein in 'autophagy'

Discovery highlights unexpected role for killer protein in 'autophagy'

PACAP hormone levels linked to post-traumatic stress disorder

PACAP hormone levels linked to post-traumatic stress disorder

Scientists find p27Kip1 protein expression in adult and aged human inner ear

Scientists find p27Kip1 protein expression in adult and aged human inner ear

Study: Heparin plays a key role in mast cell-driven allergic and inflammatory reactions

Study: Heparin plays a key role in mast cell-driven allergic and inflammatory reactions

Study: AEG-1 expression predicts erlotinib treatment response in patients with EGFR-mutant lung cancer

Study: AEG-1 expression predicts erlotinib treatment response in patients with EGFR-mutant lung cancer

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Roundup: In Ariz., Senate panel takes steps to end Medicaid; Mass. Gov. starts sales pitch for payment reform

Researchers to share information on delirium at ADS conference

Researchers to share information on delirium at ADS conference

New 'closed-loop' system can provide tightly controlled anesthesia in patients undergoing surgery

New 'closed-loop' system can provide tightly controlled anesthesia in patients undergoing surgery

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

New study: Multiple full-term pregnancies may have higher risk of 'triple-negative' breast cancer

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

PolyMedix completes PMX-30063 Phase 1 exposure-escalation clinical study to treat Staph infections

Steroid administration may impact immune system in children with asthma

Steroid administration may impact immune system in children with asthma

Study examines several homicides involving anesthetic drugs, outlines anesthesiologists' experiences

Study examines several homicides involving anesthetic drugs, outlines anesthesiologists' experiences

Special issue of Neuron journal provides new insight into recent advances in addiction research

Special issue of Neuron journal provides new insight into recent advances in addiction research

New strategies to improve developing countries' access to low-cost generic drugs needed, experts say

New strategies to improve developing countries' access to low-cost generic drugs needed, experts say

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.